Lv4
418 积分 2022-06-02 加入
Mavacamten for Obstructive Hypertrophic Cardiomyopathy in China
26天前
已完结
Human cardiac β-myosin powerstroke energetics: Thin filament, Pi displacement, and mutation effects
1个月前
已完结
Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures
2个月前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
2个月前
已完结
Nonsteroidal anti-inflammatory drugs in the perioperative period: current controversies and concerns
3个月前
已完结
Diagnosis and Management of Prediabetes
5个月前
已完结
A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
5个月前
已完结
Sigmoid septum: A variant of the ventricular hypertrophy or of the hypertrophic cardiomyopathy？
1年前
已完结
Gene-echocardiography: refining genotype–phenotype correlations in hypertrophic cardiomyopathy
1年前
已完结
Effect of beta-blockers and exercise restriction on the prevention of sudden cardiac death in pediatric hypertrophic cardiomyopathy
1年前
已完结
皖公网安备34019202002308
